his ocular blood flow characteristics were stable. We are uncertain about the reason for his decline in visual function, since at the time of the decline, he was maintained on oral corticosteroid and his serial ESR values were normal. None the less, we suggest that in patients who experience a progression of visual loss from GCA, despite IVMP therapy, may benefit acutely from the addition of heparin therapy.
No takes yet. Share an insight, caveat, or question.
E. Doyle (2004) studied this question.